PURPOSE: Adherence to prescribed exercise is a challenge for cancer patients undergoing treatment. The changing pattern of exercise adherence over time cannot be fully understood by an overall measure of adherence. This study was aimed to identify the trajectory of exercise adherence and its predictors for women with breast cancer during their chemotherapy. METHODS:Participants were 78 women with breast cancer assigned to the exercise arm of a randomized control trial. Based on the weekly adherence rates in time and intensity, patients were classified as good (>100%), acceptable (80-100%), and poor (<80%) adherents. Data were analyzed using ordinal logistic hierarchical linear modeling. RESULTS: The trajectories for both time and intensity adherence declined significantly. The decline in exercise-time adherence was significantly slower in women who reported higher interest in exercise. Women with higher perceived importance of exercise, early disease stage, and employed were more likely to be classified as good intensity adherents. Poorer weekly adherence for both exercise time and intensity was associated with higher fatigue level for that week. CONCLUSIONS: Adherence to exercise adherence in breast cancer patients declined as the dose of exercise prescription increased. Factors influencing overall adherence and adherence trend were identified.
RCT Entities:
PURPOSE: Adherence to prescribed exercise is a challenge for cancerpatients undergoing treatment. The changing pattern of exercise adherence over time cannot be fully understood by an overall measure of adherence. This study was aimed to identify the trajectory of exercise adherence and its predictors for women with breast cancer during their chemotherapy. METHODS:Participants were 78 women with breast cancer assigned to the exercise arm of a randomized control trial. Based on the weekly adherence rates in time and intensity, patients were classified as good (>100%), acceptable (80-100%), and poor (<80%) adherents. Data were analyzed using ordinal logistic hierarchical linear modeling. RESULTS: The trajectories for both time and intensity adherence declined significantly. The decline in exercise-time adherence was significantly slower in women who reported higher interest in exercise. Women with higher perceived importance of exercise, early disease stage, and employed were more likely to be classified as good intensity adherents. Poorer weekly adherence for both exercise time and intensity was associated with higher fatigue level for that week. CONCLUSIONS: Adherence to exercise adherence in breast cancerpatients declined as the dose of exercise prescription increased. Factors influencing overall adherence and adherence trend were identified.
Authors: Michael G Perri; Stephen D Anton; Patricia E Durning; Timothy U Ketterson; Sumner J Sydeman; Nicole E Berlant; William F Kanasky; Robert L Newton; Marian C Limacher; A Daniel Martin Journal: Health Psychol Date: 2002-09 Impact factor: 4.267
Authors: Victoria Mock; Constantine Frangakis; Nancy E Davidson; Mary E Ropka; Mary Pickett; Barbara Poniatowski; Kerry J Stewart; Lane Cameron; Kristin Zawacki; Laura J Podewils; Gary Cohen; Ruth McCorkle Journal: Psychooncology Date: 2005-06 Impact factor: 3.894
Authors: Kerry S Courneya; Donald C McKenzie; Robert D Reid; John R Mackey; Karen Gelmon; Christine M Friedenreich; Aliya B Ladha; Caroline Proulx; Kirstin Lane; Jeffrey K Vallance; Roanne J Segal Journal: Ann Behav Med Date: 2008-02-20
Authors: Melinda L Irwin; Lisa Cadmus; Marty Alvarez-Reeves; Mary O'Neil; Eileen Mierzejewski; Rebecca Latka; Herbert Yu; Loretta Dipietro; Beth Jones; M Tish Knobf; Gina G Chung; Susan T Mayne Journal: Cancer Date: 2008-06-01 Impact factor: 6.860
Authors: Wendy Demark-Wahnefried; L Douglas Case; Kimberly Blackwell; P Kelly Marcom; William Kraus; Noreen Aziz; Denise Clutter Snyder; Jeffrey K Giguere; Edward Shaw Journal: Clin Breast Cancer Date: 2008-02 Impact factor: 3.225
Authors: Kelcey A Bland; Sarah E Neil-Sztramko; Amy A Kirkham; Alis Bonsignore; Cheri L Van Patten; Donald C McKenzie; Karen A Gelmon; Kristin L Campbell Journal: Support Care Cancer Date: 2018-04-13 Impact factor: 3.603
Authors: Gabriel M Pagnotti; Maya Styner; Gunes Uzer; Vihitaben S Patel; Laura E Wright; Kirsten K Ness; Theresa A Guise; Janet Rubin; Clinton T Rubin Journal: Nat Rev Endocrinol Date: 2019-06 Impact factor: 43.330
Authors: Sue Kim; Yun Hee Ko; Yoonkyung Song; Min Jae Kang; Hyojin Lee; Sung Hae Kim; Justin Y Jeon; Young Up Cho; Gihong Yi; Jeehee Han Journal: Support Care Cancer Date: 2019-04-10 Impact factor: 3.603
Authors: Jessica McNeil; Mina Fahim; Chelsea R Stone; Rachel O'Reilly; Kerry S Courneya; Christine M Friedenreich Journal: J Cancer Surviv Date: 2021-03-22 Impact factor: 4.442
Authors: Ingrid C Cnossen; Cornelia F van Uden-Kraan; Birgit I Witte; Yke J Aalders; Cees J T de Goede; Remco de Bree; Patricia Doornaert; Derek H F Rietveld; Jan Buter; Johannes A Langendijk; C René Leemans; Irma M Verdonck-de Leeuw Journal: Eur Arch Otorhinolaryngol Date: 2016-11-03 Impact factor: 2.503
Authors: Lenja Witlox; Miranda J Velthuis; Jennifer H Boer; Charlotte N Steins Bisschop; Elsken van der Wall; Wout J T M van der Meulen; Carin D Schröder; Petra H M Peeters; Anne M May Journal: PLoS One Date: 2019-05-08 Impact factor: 3.240
Authors: Rebecca R Turner; Liz Steed; Helen Quirk; Rosa U Greasley; John M Saxton; Stephanie Jc Taylor; Derek J Rosario; Mohamed A Thaha; Liam Bourke Journal: Cochrane Database Syst Rev Date: 2018-09-19